Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Borg

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Acta Oncologica (Stockholm, Sweden)|November 3, 2025
Pulmonary nodules in Denmark: occurrence, resource use, and risk of lung cancer and deathCecilia Hvitfeldt Fuglsang, Ina Trolle Andersen, Frederik Pagh Bredahl Kristensen, et al.
Journal of Cancer Policy|January 7, 2026
Current opinions on lung cancer screening in the Nordic countries: A survey-based studyMorten Borg, Kirill Neumann, Jannie Christina Frølund, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2021
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohortMorten Borg, Sara W C Wen, Line Nederby, et al.
The Journal of International Medical Research|June 30, 2022
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patientsMorten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, et al.
Cancer Biomarkers : Section a of Disease Markers|November 21, 2022
Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohortMorten Borg, Line Nederby, Sara Witting Christensen Wen, et al.
Clinical Lung Cancer|March 19, 2026
Response to Letter to the EditorMargrethe Bang Henriksen, Ole Hilberg, Christian Juul, et al.
Clinical Lung Cancer|July 1, 2025
Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlagMargrethe Bang Henriksen, Ole Hilberg, Christian Juul, et al.
Frontiers in Health Services|December 25, 2025
Integrating smoking cessation support during lung cancer diagnostic workup: a pragmatic, multicenter, cluster-randomised controlled trialIngeborg Farver-Vestergaard, Kaare Bro Wellnitz, Ole Hilberg, et al.
Respiration; International Review of Thoracic Diseases|January 22, 2024
Consequences of Losing Incidental Pulmonary Nodules to Follow-Up: Unmonitored Nodules Progressing to Stage IV Lung CancerMorten Borg, Katrine Kristensen, Gitte Alstrup, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Acta Oncologica (Stockholm, Sweden)|November 3, 2025
Pulmonary nodules in Denmark: occurrence, resource use, and risk of lung cancer and deathCecilia Hvitfeldt Fuglsang, Ina Trolle Andersen, Frederik Pagh Bredahl Kristensen, et al.
Journal of Cancer Policy|January 7, 2026
Current opinions on lung cancer screening in the Nordic countries: A survey-based studyMorten Borg, Kirill Neumann, Jannie Christina Frølund, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2021
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohortMorten Borg, Sara W C Wen, Line Nederby, et al.
The Journal of International Medical Research|June 30, 2022
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patientsMorten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, et al.
Cancer Biomarkers : Section a of Disease Markers|November 21, 2022
Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohortMorten Borg, Line Nederby, Sara Witting Christensen Wen, et al.
Clinical Lung Cancer|March 19, 2026
Response to Letter to the EditorMargrethe Bang Henriksen, Ole Hilberg, Christian Juul, et al.
Clinical Lung Cancer|July 1, 2025
Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlagMargrethe Bang Henriksen, Ole Hilberg, Christian Juul, et al.
Frontiers in Health Services|December 25, 2025
Integrating smoking cessation support during lung cancer diagnostic workup: a pragmatic, multicenter, cluster-randomised controlled trialIngeborg Farver-Vestergaard, Kaare Bro Wellnitz, Ole Hilberg, et al.
Respiration; International Review of Thoracic Diseases|January 22, 2024
Consequences of Losing Incidental Pulmonary Nodules to Follow-Up: Unmonitored Nodules Progressing to Stage IV Lung CancerMorten Borg, Katrine Kristensen, Gitte Alstrup, et al.
Pageof 3